Movement Disorders

Movement disorders are a group of nervous system disorders that increase or decrease voluntary or involuntary movements. Here is the latest research on genetic and environmental factors, as well as mechanisms that underlie movement disorders.

January 17, 2021
Open Access

Inhibition of mitochondrial complex II in neuronal cells triggers unique pathways culminating in autophagy with implications for neurodegeneration

Scientific Reports
Sathyanarayanan RanganayakiMuchukunte Mukunda Srinivas Bharath
January 19, 2021

The co-occurrence of idiopathic normal pressure hydrocephalus like MRI features in progressive supranuclear palsy?

European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies
Halil Onder
January 20, 2021

Video electroencephalogram combined with electromyography in the diagnosis of hyperkinetic movement disorders with an unknown cause

Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Jianhua ChenYan Huang
January 19, 2021

Clinical and biochemical heterogeneity of Parkinson's disease

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Kh I KhadzievaA A Plotnikov
January 19, 2021
Review

Recent advances in enzymeless-based electrochemical sensors to diagnose neurodegenerative diseases

Journal of Materials Chemistry. B, Materials for Biology and Medicine
Zeyu SongXiaoying Tang
January 19, 2021

Sleep disorders in patients with cervical dystonia

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
M A SamushiyaE I Ivannikova
January 20, 2021

Altered frontal-mediated inhibition and white matter connectivity in pediatric chronic tic disorders

Experimental Brain Research
Adrienne B BruceSteve W Wu
January 20, 2021

MRI Linear Measurements in Normal Pressure Hydrocephalus Versus Progressive Supranuclear Palsy

Movement Disorders : Official Journal of the Movement Disorder Society
Lorenzo UggaArturo Brunetti
January 20, 2021

Reply to: 'Letter to the Editor on "Copathology Progressive Supranuclear Palsy: Does It Matter?"'

Movement Disorders : Official Journal of the Movement Disorder Society
Milica Jecmenica-LukicGünter Höglinger
January 20, 2021

Hyperhomocysteinemia and Dementia Associated With Severe Cortical Atrophy, but No Amyloid Burden

Journal of Geriatric Psychiatry and Neurology
Alessandro Reffo, Carlo Gabelli
January 18, 2021
Preprint
Open Access

Sleep Disorders and Gout in Australian Adults

ResearchSquare
Julia New-TolleyCatherine Hill
January 18, 2021
Comment / Editorial

When patients lead: An editorial to 'self-concocted, curious, and creative coping strategies in movement disorders' by Mulroy et al

Parkinsonism & Related Disorders
Adam Margolius, Hubert H Fernandez
January 20, 2021

Reply to: "MRI Linear Measurements in Normal Pressure Hydrocephalus Versus Progressive Supranuclear Palsy"

Movement Disorders : Official Journal of the Movement Disorder Society
Andrea QuattroneAldo Quattrone
January 20, 2021

The 3-Item "Apathy" Subscale Within the GDS-15 Is Not Supported in De Novo Parkinson's Disease Patients: Analysis of the PPMI Cohort

Journal of Geriatric Psychiatry and Neurology
Sarah M SzymkowiczPamela E May
January 17, 2021

Long-term effects of pallidal and thalamic deep brain stimulation in Myoclonus Dystonia

European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies
Patricia KrauseAndrea A Kühn
January 17, 2021

PLA2G6-Associated Dystonia Parkinsonism

Indian Pediatrics
Deepak SachanDinesh Yadav
January 19, 2021
Case Report
Open Access

Essential palatal myoclonus. A pediatric case report

Archivos argentinos de pediatría
Roxana SpiniLilian Ibarra
January 17, 2021
Comment / Editorial

Therapeutic Advances in Movement Disorders

Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics
Caroline M Tanner, Jill L Ostrem
January 17, 2021
Open Access

Predicting long-term neurodevelopmental outcomes in very preterm neonates by umbilical cord gas parameters

American Journal of Obstetrics & Gynecology MFM
Sima H BaalbakiAkila Subramaniam

Sign up to follow this feed and discover related papers.

Related Feeds

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Alpha-Synuclein Structure & Function

α-Synuclein is an integral component of Lewy bodies which are comprised of protein clumps and are a pathological hallmark of Parkinson’s disease. Here is the latest research on α-synuclein structure and function.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

Antisense Oligonucleotide Therapies: ND

Antisense oligonucleotides are synthetic DNA oligomers that hybridize to a target RNA. This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases.

Astrocytes & Huntington’s Disease

Astrocytes are abundant within the central nervous system and their dysfunction has been thought to be an important contributor to some neurodegenerative diseases, in particular Huntington’s disease. Damage to these cells may make neurons more susceptible to degeneration. Here is the latest research on astrocytes and Huntington’s disease.

Astrocytes & Neurodegeneration

Astrocytes are important for the health and function of the central nervous system. When these cells stop functioning properly, either through gain of function or loss of homeostatic controls, neurodegenerative diseases can occur. Here is the latest research on astrocytes and neurodegeneration.

Ataxias

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on different types of ataxias here.

© 2021 Meta ULC. All rights reserved
/feed-previews/movement-disorders/1f0836ee-eb20-40e9-b195-7da169d86bba